APA (7th ed.) Citation

Tepper, S. J., Schytz, H. W., Jensen, R. H., Lundqvist, C., Terwindt, G. M., Tassorelli, C., . . . Lipton, R. B. (2026). Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial. Cephalalgia, 46(5), 1. https://doi.org/10.1177/03331024261449814

Chicago Style (17th ed.) Citation

Tepper, Stewart J., et al. "Benefits of Eptinezumab on Patient-reported Disease Burden and Health-related Quality of Life in Adults with Chronic Migraine and Medication-overuse Headache: Results from the Placebo-controlled RESOLUTION Trial." Cephalalgia 46, no. 5 (2026): 1. https://doi.org/10.1177/03331024261449814.

MLA (9th ed.) Citation

Tepper, Stewart J., et al. "Benefits of Eptinezumab on Patient-reported Disease Burden and Health-related Quality of Life in Adults with Chronic Migraine and Medication-overuse Headache: Results from the Placebo-controlled RESOLUTION Trial." Cephalalgia, vol. 46, no. 5, 2026, p. 1, https://doi.org/10.1177/03331024261449814.